In the News August 3, 2018

Bloomberg Law | Stem Cell Clinics Face Long Odds against FDA in Legal Fight

Marc Scheineson is quoted on how legal actions by the U.S. Food and Drug Administration against stem cell clinics are shaping regenerative medicine regulations.
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222
This website uses cookies to improve functionality and performance. By continuing to browse this site, you are consenting to the use of cookies on this website. For details, see our Privacy Statement